Prosecution Insights
Last updated: May 29, 2026
Application No. 17/478,784

MINIMALLY INVASIVE SURGERY ABLATION CLAMP WITH CAM MECHANISM

Non-Final OA §112
Filed
Sep 17, 2021
Priority
Dec 10, 2020 — provisional 63/123,810
Examiner
GUERRERO ROSARIO, ANA VERUSKA
Art Unit
3794
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
AtriCure, Inc.
OA Round
7 (Non-Final)
48%
Grant Probability
Moderate
7-8
OA Rounds
0m
Est. Remaining
96%
With Interview

Examiner Intelligence

Grants 48% of resolved cases
48%
Career Allowance Rate
26 granted / 54 resolved
-21.9% vs TC avg
Strong +48% interview lift
Without
With
+48.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 11m
Avg Prosecution
30 currently pending
Career history
103
Total Applications
across all art units

Statute-Specific Performance

§103
70.1%
+30.1% vs TC avg
§102
5.3%
-34.7% vs TC avg
§112
1.7%
-38.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 54 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 03/17/2026 has been entered. Response to Amendment The Amendments filed March 17, 2026 have been entered. Applicant’s amendments have overcome the 112b and 101 rejections previously set-forth in the Final Rejection mailed on 01/09/2026. Currently, claims 1, 8, 16, and 20 have been amended, and claims 1, 3-10, 12-21, 25, 27-31 are pending in the application. Drawings The drawings are objected to under 37 CFR 1.83(a). The drawings must show every feature of the invention specified in the claims. Therefore, the second insulating pad contacting the first insulating pad when the tissue grabbing apparatus is in a closed position as required by claims 1, 8, and 16 must be shown or the feature(s) canceled from the claim(s). The Examiner notes additional details regarding these at-issue limitations can be found in the rejection under 35 U.S.C. 112(a) below. No new matter should be entered. Corrected drawing sheets in compliance with 37 CFR 1.121(d) are required in reply to the Office action to avoid abandonment of the application. Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. The figure or figure number of an amended drawing should not be labeled as “amended.” If a drawing figure is to be canceled, the appropriate figure must be removed from the replacement sheet, and where necessary, the remaining figures must be renumbered and appropriate changes made to the brief description of the several views of the drawings for consistency. Additional replacement sheets may be necessary to show the renumbering of the remaining figures. Each drawing sheet submitted after the filing date of an application must be labeled in the top margin as either “Replacement Sheet” or “New Sheet” pursuant to 37 CFR 1.121(d). If the changes are not accepted by the examiner, the applicant will be notified and informed of any required corrective action in the next Office action. The objection to the drawings will not be held in abeyance. Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 1, 3-10, 12-21, 25, 27-31 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. Regarding independent claims 1, 8 and 16, the claims presently recite “wherein the second insulating pad contacts the first insulating pad when the tissue grabbing apparatus is in a closed position”. The Examiner has reviewed the instant disclosure and has identified that there is no sufficient evidence, either in the Specification or Drawings to support the at-issue claim limitation. Specifically, paragraph [0073] of the filed Specification provides a description of a) a closed configuration that is not “fully closed” given that tissue is located between the jaws 114 and 116 and b) a closed configuration of the jaws when tissue is not grasped by the gripping surfaces as illustrated in figure 5B. The Examiner notes that the multiple other recitations in the Specification discuss the jaws to ”close” with the jaws having tissue disposed therebetween (see [0003], [0014], [0101], [0149] and [0152]). Other recitations in the disclosure discuss the jaws to be closed in a manner such that the jaws remain parallel to one another (see [0014] and [0072]). Neither these cited portions nor any other portion of the disclosure in the Specification provides any manner of implicit or explicit support or evidence that there is specifically contact between the first insulating pad and the second insulating pad when the jaws are in the closed position as required in each of claims 1, 8 and 16. Similarly, none of the figures including Figure 5B (as reference in paragraph [0073] above) provide a clear enough illustration of the closed position to show that contact between the first insulating pad and the second insulating pad actually occurs. Thus, is the Examiner’s position that the requirement in claims 1, 8, and 16 of the second insulating pad contacting the first insulating pad when the tissue grabbing apparatus is in a closed position was not described in the Specification or illustrated in the Drawings in such a way as to reasonably convey to one of ordinary skill in the art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention given that the disclosure specifically provides that the first and second insulating pads are, at best, near each other when the jaws are in the closed configuration. Claims 3-7, 9-10, 12-15, 17-21, 25, 27-31 are also rejected because they are respectively dependent on claims 1, 8 and 16. Appropriate correction is required. Response to Arguments Applicant’s arguments filed 03/17/2026 with respect to claims 1, 8, 16 have been considered but are moot because in light of the newly proffered rejection of the pending claims under 35 U.S.C. 112(a) above, the Examiner does not acquiesce to any arguments made against the prior art and reserves the right to revisit the prior art in based upon any subsequent response. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ANA VERUSKA GUERRERO ROSARIO whose telephone number is (571)272-6976. The examiner can normally be reached Monday - Thursday 7:00 - 4:30 PM EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Stoklosa can be reached at (571) 272-1213. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /A.V.G./Examiner, Art Unit 3794 /Ronald Hupczey, Jr./Primary Examiner, Art Unit 3794
Read full office action

Prosecution Timeline

Show 14 earlier events
Oct 20, 2025
Response Filed
Jan 09, 2026
Final Rejection mailed — §112
Feb 09, 2026
Response after Non-Final Action
Mar 17, 2026
Request for Continued Examination
Apr 07, 2026
Response after Non-Final Action
Apr 29, 2026
Non-Final Rejection mailed — §112
May 21, 2026
Applicant Interview (Telephonic)
May 21, 2026
Examiner Interview Summary

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12622738
MEDICAL DEVICES AND RELATED METHODS
4y 11m to grant Granted May 12, 2026
Patent 12616517
EXPANDABLE BASKET ASSEMBLIES WITH LINEAR SPINE PATTERNS FOR IMPROVED TISSUE CONTACT AND METHODS FOR MAKING THEREOF
3y 2m to grant Granted May 05, 2026
Patent 12605201
SYSTEM, DEVICE, AND METHOD FOR DETERMINING LOCATION OF ARRHYTHMOGENIC FOCI
4y 2m to grant Granted Apr 21, 2026
Patent 12582464
SYSTEM, DEVICE, AND METHOD FOR DETERMINING LOCATION OF ARRHYTHMOGENIC FOCI
4y 2m to grant Granted Mar 24, 2026
Patent 12527505
BIOELECTRODE AND METHOD FOR PRODUCING BIOELECTRODE
5y 4m to grant Granted Jan 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

7-8
Expected OA Rounds
48%
Grant Probability
96%
With Interview (+48.4%)
3y 11m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 54 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month